Tag: brain

quicktome omniscient neurotechnology

Omniscient Neurotechnology launches Quicktome brain-mapping platform following FDA clearance

Omniscient Neurotechnology has received US Food and Drug Administration (FDA) 510(k) clearance for Quicktome—a digital brain-mapping platform that allows neurosurgeons to visualise and understand...
Omniscient Neurotechnology

Omniscient Neurotechnology raises AUD$40 million in Series B financing

Omniscient Neurotechnology, a Sydney-based brain-mapping technology company, has announced the completion of a AUD$40 million Series B financing round. The funding will allow Omniscient...

RegeneRX receives Canadian patent for treating neurological injury and damage

RegeneRx Biopharmaceuticals has announced that the Canadian Patent Office has issued a Notice of Allowance for Thymosin beta 4 (Tβ4) for use in the treatment...

Endovantage gains US FDA 510(k) clearance for Surgicalpreview

Endovantage has announced receiving 510(k) clearance from the US FDA for Surgicalpreview, its preoperative planning system for the endovascular treatment of cerebral aneurysms. Precise sizing...

TAVI Linked with bleeding in the brain and neurological impairment

Of 84 older patients undergoing transcatheter aortic valve implantationt (TAVI), nearly a quarter developed new microbleeds in the brain after their procedure, according to...